Cargando…
The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
Ovarian cancer (OvCA) accounts for one of the leading causes of death from gynecologic malignancy. Despite progress in therapy improvements in OvCA, most patients develop a recurrence after first-line treatments, dependent on the tumor and non-tumor complexity/heterogeneity of the neoplasm and its s...
Autores principales: | Baci, Denisa, Bosi, Annalisa, Gallazzi, Matteo, Rizzi, Manuela, Noonan, Douglas M., Poggi, Alessandro, Bruno, Antonino, Mortara, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247443/ https://www.ncbi.nlm.nih.gov/pubmed/32354198 http://dx.doi.org/10.3390/ijms21093125 |
Ejemplares similares
-
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis
por: Baci, Denisa, et al.
Publicado: (2020) -
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors
por: Palano, Maria Teresa, et al.
Publicado: (2022) -
Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
por: Bassani, Barbara, et al.
Publicado: (2019) -
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors
por: Gallazzi, Matteo, et al.
Publicado: (2021) -
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
por: Acquati, Francesco, et al.
Publicado: (2019)